Get started
Author

Nela Klein-González

Observed names: N Klein-Gonzalez, N Klein-González, N. Klein-González, Nela Klein Gonzalez, Nela Klein González, Nela Klein-Gonzalez, Nela Klein‐Gonzalez
Observed institutions: Universitat Autònoma de Barcelona, University of Cologne, Instituto de Salud Carlos III, Vall d'Hebron Institut de Recerca, Hospital Clínic de Barcelona, Vall d'Hebron Hospital Universitari, CaixaBank, Banc de Sang i Teixits, University Hospital Cologne, Fundació Clínic per a la Recerca Biomèdica, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Barcelona Activa, Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer, Monash University, Universitat de Barcelona
ORCID: 0000-0002-4593-6457
Observed ORCID: 0000-0002-4593-6457
OpenAlex ID: A5033353535
Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-Analysis
2011 · Andreas Draube, Nela Klein-González, et al. · PLoS ONE · 219
PDF
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies
2020 · Valentín Ortíz-Maldonado, Susana Rives, et al. · Molecular Therapy · 176
PDF
Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure
2021 · Mireia Uribe-Herranz, Nela Klein-González, et al. · International Journal of Molecular Sciences · 84
PDF
CD40-activated B cells induce anti-tumor immunityin vivo
2016 · Kerstin Wennhold, Tanja M. Weber, et al. · Oncotarget · 64
PDF
CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential
2008 · E Kondo, L Gryschok, et al. · Clinical & Experimental Immunology · 45
Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development
2023 · Lorena Pérez-Amill, Àlex Bataller, et al. · Frontiers in Immunology · 26
PDF
In vitroandin vivoimaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy
2015 · Nela Klein Gonzalez, Kerstin Wennhold, et al. · OncoImmunology · 21
PDF
Murine Model of CD40-activation of B cells
2010 · Tanja M. Liebig, Anne Fiedler, et al. · Journal of Visualized Experiments · 14
PDF
Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
2025 · Mireia Uribe-Herranz, Aina Oliver-Caldés, et al. · Blood Cancer Discovery · 12
CD84: A Novel Target for CAR T-Cell Therapy for Acute Myeloid Leukemia
2022 · Lorena Pérez-Amill, Mercedes Armand-Ugon, et al. · Blood · 12
The cyclins: a family of widely expressed tumor antigens?
2011 · Michael S von Bergwelt-Baildon, Eisei Kondo, et al. · Expert Review of Vaccines · 11
The shared tumor associated antigen cyclin‐A2 is recognized by high‐avidity T‐cells
2009 · Eisei Kondo, Britta Maecker, et al. · International Journal of Cancer · 10
PDF
A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias
2025 · Lorena Pérez-Amill, Mercedes Armand-Ugón, et al. · Leukemia · 9
PDF
A Quantitative Approach to Potency Testing for Chimeric Antigen Receptor-Encoding Lentiviral Vectors and Autologous CAR-T Cell Products, Using Flow Cytometry
2025 · Juan José Mata-Molanes, Leticia Alserawan, et al. · Pharmaceutics · 6
Targeting malignant B cells as antigen-presenting cells: TLR-9 agonist induces systemic regression of lymphoma
2011 · Nela Klein-González, Udo Holtick, et al. · Expert Review of Vaccines · 4
T-cell responses against CD19-targeted CAR T cells varnimcabtagene autoleucel (ARI-0001): implications for immune response and therapy outcomes
2025 · Ariadna Bartoló-Ibars, Andrea Aran, et al. · Journal for ImmunoTherapy of Cancer · 3
PDF
P1356: Cd84-targeted Cart-cell Therapy: a Novel Strategy for the Treatment of Haematological Malignancies
2023 · Lorenza Pérez Amill, Mercedes Armand Ugon, et al. · HemaSphere · 3
In Vitro and in Vivo Imaging of Initial T-B Cell Interactions in the Setting of B Cell-Based Cancer Immunotherapy
2014 · Kerstin Wennhold, Nela Klein-Gonzalez, et al. · Blood · 2
Potential of Toll-Like Receptor 9 Agonists in Combined Anticancer Immunotherapy Strategies: Synergy of PAMPs and DAMPs?
2011 · Udo Holtick, Nela Klein-Gonzalez, et al. · Immunotherapy · 2
CD40-Activated B Cells Migrate Towards Secondary Lymphoid Organs And Interact Dynamically With T Cells
2010 · N. Klein-González, S. Balkow, et al. · Transplantation and Cellular Therapy · 2
PDF
Proving the principle: dendritic cell-based vaccines in urogenital cancers
2011 · Andreas Draube, Nela Klein-González, et al. · Expert Review of Vaccines · 1
PDF
Cyclins Against Cancer: A Novel Family of Tumor Antigens?
2010 · Nela Klein-González, Eisei Kondo, et al. · Immunotherapy · 1
CD84 Expression Across Disease Stages and Leukemic Subpopulations in Acute Myeloid Leukemia
2026 · Beatriz Martín-Herreros, Lourdes Cordón, et al. · Cancers
Impact of IL-21 on CAR T-cell manufacturing: phenotypic, metabolic, and functional outcomes
2026 · Maria Val-Casals, Ane Altuna, et al. · Frontiers in Immunology
PDF
Supplementary Table 13 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma
2025 · Mireia Uribe-Herranz, Aina Oliver-Caldés, et al.
PDF
Works count: 72
Citation count: 727
H-index: 11
I10-index: 12
Year
Topic
Type